MedTrace Logo

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

NCT05500391 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2026-03-18

No results posted yet for this study

Summary

This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).

Conditions

  • Stage I Testicular Seminoma
  • Stage I Testicular Nonseminomatous Germ Cell Tumor
  • Gastrointestinal Stromal Tumors
  • Ovarian Germ Cell Tumor
  • Adenocarcinoma, Clear Cell
  • Borderline Ovarian Tumor
  • Sex Cord-Stromal Tumor
  • Mucinous Adenocarcinoma of Ovary
  • Carcinoma, Small Cell
  • Carcinosarcoma, Ovarian
  • Serous Tumor of Ovary
  • Glioma
  • Neuroendocrine Tumors
  • Aggressive Fibromatosis of Abdominal Wall (Disorder)

Interventions

OTHER

Oncological Follow-up

Post-cancer surveillance (including biological, clinical and imaging exams depending on the condition)

Sponsors & Collaborators

  • Canceropôle Nord Ouest

    collaborator OTHER

  • Groupement Interrégional de Recherche Clinique et d'Innovation

    collaborator OTHER

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • PENEL Nicolas, MD, PhD · Centre Oscar Lambret

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-28
Primary Completion
2026-10-31
Completion
2032-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05500391 on ClinicalTrials.gov